13th Annual Pharma & Biotech Licensing Deal Making Summit Creates Unparalleled Opportunities for Partnerships, Financing and Investment Options for Growth.

NEW YORK -- ALM's Strategic Research Institute today announced that the 13(th) Annual Pharma & Biotech Licensing & Deal Making Summit will be held May 15-16, 2008 at Hyatt Regency New Brunswick, New Brunswick, NJ.

Bringing together leading business development professionals, researchers and top tier investors, this event promises to create opportunities to network and develop key partnerships critical to successful pharmaceutical and biotechnology deals Attendees will also discover financing and investment options for growth while mingling with elite representatives from big pharma, biotech and academia.

"As leading brands' patents expire and generic competition increases, pharmaceutical companies must gain access to new products and therapeutic areas in early-stage development to stay competitive," said Kathleen Stewart, Managing Director of ALM's Strategic Research Institute. "Increasingly, big pharma's are buying start-up biotechs simply to acquire their products or licenses, creating win-win deals for all involved. This conference brings just-in-time coverage of hottest topics in licensing and deal-making for the industry."

Featuring an all-star speaker faculty, only the 13th Annual Pharma & Biotech Licensing & Deal Making Summit has the view from both sides on selection criteria for picking pharmaceutical & biotech partners, winning innovative deal structures used at phase II, and the latest developments in antibody discovery and financing to cultivate partnerships and gain funding for maximum growth. With top tier speakers widely representing the industry, attendees are sure to expand their contacts.

Confirmed speakers include representatives from GENENTECH INC, MERCK & CO., INC, GLAXOSMITHKLINE, BIOGEN IDEC, PFIZER AND BOERINGER INGELHEIM.

For complete program agenda and information including registration and hotel booking, please visit www.almevents.com/pharmadeals.

For information on becoming a sponsor or exhibitor, please call Henry Dicker 212-967-0095 ext. 263 or email [e-mail].

To become a media partner, please contact Cheryl Kahan-Radhuber at 212.967.0095, ext. 273 or [e-mail].

The Strategic Research Institute is part of ALM's Conference and Trade Show Division, one of North America's largest producers of educational and networking events for business leaders and the legal profession. The division offers more than 200 conferences and two leading industry tradeshows annually, on a broad range of topics.

ALM is a leading integrated media company, focused on the legal, real estate and business communities. ALM currently publishes 33 national and regional magazines and newspapers. Other ALM businesses include online, book and newsletter publishing, market research and content distribution. More information on ALM is available at www.alm.com. ALM is an Incisive Media company.

Incisive Media is a rapidly growing provider of specialist business information, in print, in person and online. Incisive Media operates in four principal markets: financial services, risk management, professional services and marketing services. Incisive Media's market leading brands include Investment Week, Post Magazine, Risk, Search Engine Strategies, Accountancy Age, Professional Pensions, Computing and Legal Week. For more information, visit www.incisivemedia.com.